The HSPA1B Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HeLa human cervical carcinoma cell line. Disruption of the endogenous HSPA1B gene eliminates expression of the stress-inducible Hsp70-1 chaperone, creating a loss-of-function model to investigate cellular stress responses and apoptosis regulation. This polyclonal population preserves the genetic heterogeneity of the original pool of edited cells, providing a robust system for functional studies without the bias of single-cell clonal selection. The CRISPR/Cas9-mediated gene disruption serves as a versatile tool for probing the molecular mechanisms governed by Hsp70-1 in cancer biology and beyond.
HeLa cells, originally derived from a cervical adenocarcinoma, are immortalized epithelial cells that serve as a widely characterized model for cancer research. These cells harbor integrated human papillomavirus type 18 (HPV18) DNA, leading to expression of the viral oncoproteins E6 and E7, which inactivate the tumor suppressors p53 and retinoblastoma protein (Rb), respectively. Consequently, HeLa cells exhibit dysregulated cell cycle control and resistance to apoptosis, mirroring key features of tumorigenesis. Their robust and reproducible growth in culture, coupled with extensive genetic and biochemical annotation, makes HeLa an exemplary host for generating gene-edited derivatives to dissect molecular pathways involved in oncogenesis and cellular homeostasis.
HSPA1B encodes Hsp70-1, a major stress-inducible molecular chaperone essential for protein folding, refolding, and prevention of aggregation under proteotoxic conditions. It is transcriptionally activated by HSF1 in response to heat shock, oxidative stress, and TNF-alpha signaling. Hsp70-1 directly interacts with co-chaperones such as HSP40, BAG family members, CHIP, and HOP to facilitate substrate processing and fate determination. Crucially, Hsp70-1 suppresses apoptosis by binding Apaf-1 to inhibit apoptosome formation and caspase-3 activation, and by interacting with AIF to block chromatin condensation. It also stabilizes lysosomes, preventing cathepsin release and subsequent cell death. Additionally, Hsp70-1 modulates prosurvival signaling through interactions with Akt, PKC, JNK, and NF-kB pathways, thus integrating stress signals with cell fate decisions.
In the HeLa cervical cancer background, HSPA1B knockout disrupts a critical node in cellular stress adaptation. Hsp70-1 overexpression in cancers contributes to chemoresistance, so its deletion allows study of sensitization to therapies. Loss of Hsp70-1 in HPV-immortalized cells may expose synthetic vulnerabilities related to lysosomal integrity and apoptosis, given compromised p53 and Rb. This polyclonal model investigates Hsp70-1 prosurvival mechanisms intersecting with oncogenic stress and therapy resistance.
Researchers can employ these polyclonal knockout cells to dissect stress response and apoptosis regulation. Key applications include Western blotting and RT?qPCR for expression analysis, Annexin V/PI apoptosis assays, and cell viability assays under heat shock or oxidative stress. Immunofluorescence and co?immunoprecipitation reveal alterations in Hsp70-1 interactomes. The model also supports drug sensitivity screening, migration/invasion assays, and proteasome activity measurements. For further information or technical support, please contact Ascent Research.
